Literature DB >> 30827846

Abnormal preschool Lung Clearance Index (LCI) reflects clinical status and predicts lower spirometry later in childhood in cystic fibrosis.

K M Hardaker1, H Panda2, K Hulme2, A Wong1, E Coward1, P Cooper1, D A Fitzgerald3, C Pandit1, S Towns1, H Selvadurai3, P D Robinson4.   

Abstract

BACKGROUND: Clinical and prognostic value of preschool Multiple Breath Washout (MBW) remains unclear.
METHODS: Initial MBW results (Exhalyzer® D, EcoMedics AG) in preschool Cystic Fibrosis (CF) subjects (age 2-6 years) at a time of clinical stability were compared to (1) concurrent clinical status measures and (2) later spirometry outcomes. Abnormal Lung Clearance Index (LCI) was defined using published reference data (ULN for LCI 8.0).
RESULTS: LCI was abnormal in 56% (28/50), with mean (SD) LCI 8.61(1.85) at age 4.71(1.3) years. Abnormal LCI was associated with higher dornase alfa use, previous positive bacterial cultures and pF508.del homozygous genotype. Later spirometry (n = 44; mean (SD) 2.3(0.5) years after MBW) demonstrated that abnormal initial preschool LCI was a strong predictor of lower later spirometry outcomes.
CONCLUSION: Abnormal preschool LCI was associated with concurrent measures of clinical status and later spirometry deficits, suggesting early prognostic utility of MBW testing in this age range.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cystic fibrosis; Multiple breath washout; Preschool; Spirometry

Year:  2019        PMID: 30827846     DOI: 10.1016/j.jcf.2019.02.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.

Authors:  BreAnna Kinghorn; Sharon McNamara; Alan Genatossio; Erin Sullivan; Molly Siegel; Irma Bauer; Charles Clem; Robin C Johnson; Miriam Davis; Anne Griffiths; William Wheeler; Katherine Johnson; Stephanie D Davis; Margaret W Leigh; Margaret Rosenfeld; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2020-09

Review 2.  Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing.

Authors:  Elpis Hatziagorou; Asterios Kampouras; Vasiliki Avramidou; Ilektra Toulia; Elisavet-Anna Chrysochoou; Maria Galogavrou; Fotios Kirvassilis; John Tsanakas
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

3.  Multiple breath washout: measuring early manifestations of lung pathology.

Authors:  Sanja Stanojevic; Cole Bowerman; Paul Robinson
Journal:  Breathe (Sheff)       Date:  2021-09

Review 4.  Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index.

Authors:  Vito Terlizzi; Chiara Castellani; Giovanni Taccetti; Beatrice Ferrari
Journal:  Ital J Pediatr       Date:  2022-08-04       Impact factor: 3.288

Review 5.  Monitoring disease progression in childhood bronchiectasis.

Authors:  Kathryn A Ramsey; André Schultz
Journal:  Front Pediatr       Date:  2022-09-16       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.